CBD Life Sciences (OTCMKTS:CBDL) Stock Moves Up 33%: But Why?

There were certain stocks which managed to come into sharp focus this past week and one of those was the CBD Life Sciences (OTCMKTS:CBDL) stock. The CBD Life Sciences stock ended the week on a strong note as it soared by as much as 33% on Friday and it seems that the rally in the stock was triggered by an announcement from the company last Wednesday.

On August 4 the company announced that its fully owned subsidiary company LBC Bioscience LLC was in the process of expanding its range of offerings through the introduction of the non-GMO, Gluten Free, Vegan Gummies.

This new line of products that the company is working on consists of edible gummies and is going to be made available in a range of flavours. Some of the available flavours are going to be coconut, blue raspberry, lemonade, candy apple and others.

The products are going to be sold in the 4 ounce jars and are going to be loaded with 20 mg of the highest quality hemp extracts. It goes without saying that it is a major development for the company and has also brought it to the attention of investors in a big way.